XCUR

Exicure (XCUR)

About Exicure (XCUR)

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Details

Daily high

$6.56

Daily low

$5.80

Price at open

$6.20

52 Week High

$22.99

52 Week Low

$3.10

Market cap

37.7M

Dividend yield

0.00%

Volume

160,601

Avg. volume

2.2M

P/E ratio

-3.93

Exicure News